Palisade Bio, Inc. (PALI)
2.01
-0.04
(-1.95%)
USD |
NASDAQ |
Sep 10, 16:00
2.05
+0.04
(+1.99%)
After-Hours: 20:00
Palisade Bio Total Liabilities (Quarterly) : 5.567M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.567M |
| March 31, 2026 | 5.953M |
| December 31, 2025 | 4.964M |
| September 30, 2025 | 3.761M |
| June 30, 2025 | 4.047M |
| March 31, 2025 | 2.859M |
| December 31, 2024 | 3.388M |
| September 30, 2024 | 2.728M |
| June 30, 2024 | 2.922M |
| March 31, 2024 | 2.588M |
| December 31, 2023 | 2.739M |
| September 30, 2023 | 2.985M |
| June 30, 2023 | 2.49M |
| March 31, 2023 | 1.515M |
| December 31, 2022 | 3.284M |
| September 30, 2022 | 3.836M |
| June 30, 2022 | 3.595M |
| March 31, 2022 | 3.558M |
| December 31, 2021 | 5.147M |
| September 30, 2021 | 12.35M |
| June 30, 2021 | 24.39M |
| March 31, 2021 | 1.186M |
| December 31, 2020 | 10.12M |
| September 30, 2020 | 1.047M |
| June 30, 2020 | 0.8674M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.383M |
| December 31, 2019 | 1.458M |
| September 30, 2019 | 1.901M |
| June 30, 2019 | 1.559M |
| March 31, 2019 | 2.134M |
| December 31, 2018 | 1.635M |
| September 30, 2018 | 3.242M |
| June 30, 2018 | 3.058M |
| March 31, 2018 | 4.943M |
| December 31, 2017 | 5.369M |
| September 30, 2017 | 4.624M |
| June 30, 2017 | 5.575M |
| March 31, 2017 | 8.949M |
| December 31, 2016 | 11.27M |
| September 30, 2016 | 12.24M |
| June 30, 2016 | 12.46M |
| March 31, 2016 | 10.37M |
| December 31, 2015 | 9.982M |
| September 30, 2015 | 12.24M |
| June 30, 2015 | 11.83M |
| March 31, 2015 | 11.44M |
| December 31, 2014 | 12.12M |
| September 30, 2014 | 8.539M |
| June 30, 2014 | 8.600M |
| March 31, 2014 | 9.027M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 127.32M |
| Shareholders Equity (Quarterly) | 121.75M |
| Current Ratio | 24.25 |
| Net Debt Paydown Yield | 0.00% |